Although further investigations should be done to verify whether SMO is the key target in lung cancer, our data is of great value forpromising combination therapy and would provide a possible solution for the improvement of individualized therapeutic and prognosis of lung cancer in the coming days. The gene discussed is SMO; the disease is lung cancer.